Recombinant Vector Vaccines


Recombinant vector vaccines are recurring drugs designed to carry additional genes taken from the pathogen - and these extra genes produce the proteins we want to be able to protect ourselves with. These vaccine molecules can change and lose additional genes during the vaccine process or during recurrence within a person, and there is concern that this evolution could severely limit the effectiveness of the vaccine. The effectiveness of this process is learned here by mathematical models. The evolutionary potential of the vaccine within the institution is reduced by the temporary increase in the number of vaccines before the immune response is suppressed.

  • Medicine Business development
  • organizations
  • Antiretroviral development

Related Conference of Recombinant Vector Vaccines

February 20-21, 2023

International Conference on Vaccine Research

Madrid, Spain
October 18-19, 2023

43rd Global Summit and Expo on Vaccines & Immunology

Vienna, Austria
November 06-07, 2023

5th World Congress on Vaccine and Immunology

Tokyo, Japan

Recombinant Vector Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in